Tiina Kirsilae

Affiliations

Novartis Pharma AG, Basel, Switzerland.

Publications (1)

A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma.

Journal of neuro-oncology

Avec: Martin van den Bent , Analia Azaro , Filip De Vos , Juan Sepulveda , W K Alfred Yung , Patrick Y Wen , Andrew B Lassman , Markus Joerger , Ghazaleh Tabatabai , Jordi Rodon , Ralph Tiedt , Sylvia Zhao , Tiina Kirsilae , Yi Cheng , Sergio Vicente , O Alejandro Balbin , Hefei Zhang , Wolfgang Wick

Réseau de co-auteurs

Martin van den Bent 1 collaboration

Analia Azaro 1 collaboration

Filip De Vos 1 collaboration

Juan Sepulveda 1 collaboration

W K Alfred Yung 1 collaboration

Patrick Y Wen 1 collaboration

Andrew B Lassman 1 collaboration

Markus Joerger 1 collaboration

Ghazaleh Tabatabai 1 collaboration

Jordi Rodon 1 collaboration

Ralph Tiedt 1 collaboration

Sylvia Zhao 1 collaboration

Yi Cheng 1 collaboration

Sergio Vicente 1 collaboration

O Alejandro Balbin 1 collaboration

Hefei Zhang 1 collaboration

Wolfgang Wick 1 collaboration